COPD: Page 5

Urine analysis can predict COPD flare-ups
Applying artificial intelligence to a urine test can forecast symptoms up to a week in advance.
November 25, 2024
Image of a urine test that uses AI and a smartphone to predict COPD flare ups
A healthier diet can lower risk for COPD
Research suggests low-carb, low-fat diets are associated with lower mortality in COPD patients.
November 20, 2024
Mature man and woman cooking healthy meal in kitchen.
A closer look at early COPD in younger patients
Researchers aim to provide insight into how COPD progresses in people with a smoking history.
November 20, 2024
Image of a man in his 30s using an inhaler.
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
CDC respiratory virus guidance
Majority of COPD, asthma patients forgo flu shots
Analysis finds about one-third of people with lung disease get vaccinated despite risks and high costs.
November 13, 2024
Graphic of flue shot bottle and needle surrounded by tiny people.
Focus on comorbidities, socioeconomic factors could boost COPD care
A more holistic approach could help address health equity.
November 13, 2024
Indian doctor uses a stethoscope on an Indian woman.
Interstitial lung abnormality in COPD is inversely associated with comorbidity of lung cancer
A retrospective cohort examined more than 1,100 COPD patients.
November 6, 2024
Representative high-resolution CT images of COPD. (A) COPD without emphysema or ILA, (B) COPD with ILA but not emphysema, (C) COPD with emphysema but not ILA, (D) COPD with emphysema and ILA.
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
Childhood neglect associated with stroke, COPD and more
Researchers find link between childhood neglect and poor adult health outcomes with possible pathways for future treatment.
November 6, 2024
Black and white photo of a depressed child sitting on a worn sidewalk.
Study reinforces Yupelri effectiveness in COPD treatment
The drug is the only FDA-approved, once-daily, nebulized long-acting muscarinic agonist.
October 30, 2024
Photo of a gloved hand putting drops of unknown liquid into test tubes with a masked medical person blurred in the background.
Phase 2 study set for COPD-related sarcopenia treatment
The study will evaluate the potential of RJx-01 to maintain muscle integrity in older people with severe COPD.
October 30, 2024
Elderly woman exercise walking in backyard with caregiver.
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
MMP-12 inhibitor shows promise in phase 1 trial
The novel and selective inhibitor could treat COPD, severe asthma and more.
October 24, 2024
Image of blocks spelling out phase 1 with the 1 being switched to 2.
FDA grants investigational clearance for new COPD, asthma drug
KT-621 is set to undergo a phase 1 clinical trial immediately.
October 24, 2024
microscope with lab glassware, science laboratory research and development concept
Biomarker can help assess the severity of COVID-19, COPD, asthma
Research is centered around IL-26, a signaling substance in the immune system.
October 17, 2024
charts showing the relationship between the plasma concentration of IL-26 and severity of COVID-19.
Previous Page
Page 5 of 15
Next Page
Most Popular
Some COPD patients may be using the wrong inhaler
Oral bacterial therapy reduces respiratory infections in asthma patients
Automated PAH screening improves outcomes
The impact of biologic treatment for asthma in older adults
Combination therapy boosts transplant-free survival outcomes
Cockroach and rodent exposure linked to poor lung function in urban children with asthma